Amryt Pharma (AMYT)

Sector:

Financials

Index:

FTSE AIM All-Share

167.50p
   
  • Change Today:
      2.50p
  • 52 Week High: 223.00
  • 52 Week Low: 155.00
  • Currency: UK Pounds
  • Shares Issued: 179.38m
  • Volume: 2,524
  • Market Cap: 300.47m

Amryt Pharma Overview

Amryt Pharma is in the financials sector and is currently trading at 167.50p per share. In the last year Amryt Pharma's share price has ranged from 155.00p to 223.00p and brokers are currently rating this stock as 'strong buy'.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -25.4% -19.6%
ROCE 230.7%  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 2.2 2.0
Pr/Book 6.2  
Latest F'cast
Revenue 214.2% -40.2%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Amryt Pharma Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-16 1.35 (7.80) (28.68)¢ n/a n/a n/a n/a 0.0%
31-Dec-17 12.78 (26.14) (70.32)¢ n/a n/a n/a n/a 0.0%
31-Dec-18 17.09 (30.44) (402.00)¢ n/a n/a n/a n/a 0.0%
31-Dec-19 58.12 (63.49) (83.00)¢ n/a n/a n/a n/a 0.0%
31-Dec-20 182.61 (105.86) (66.00)¢ n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Amryt Pharma Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-21 150.79 (29.49) (7.06)p n/a n/a n/a n/a 0.0%
31-Dec-22 226.81 29.67 11.44p 14.4 n/a n/a n/a 0.0%

Copyright © 2021 FactSet Research Systems Inc. All rights reserved.

Amryt Pharma Company Announcements

Amryt to Report Q2 2021 Results and Host Confere... 12-Jul-2021 12:00 GlobeNewswire NA
Publication of Circular to Amryt Shareholders in... 28-Jun-2021 12:00 GlobeNewswire NA
Amryt Pharma Announces Filing of Preliminary Reg... 15-Jun-2021 11:45 GlobeNewswire NA

Latest Amryt Pharma Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

Amryt Pharma Market Data

Currency UK Pounds
Share Price 167.50p
Change Today 2.50p
% Change 1.52 %
52 Week High 223.00
52 Week Low 155.00
Volume 2,524
Shares Issued 179.38m
Market Cap 300.47m

Amryt Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
56.25% below the market average56.25% below the market average56.25% below the market average56.25% below the market average56.25% below the market average
41.61% below the sector average41.61% below the sector average41.61% below the sector average41.61% below the sector average41.61% below the sector average
Price Trend
21.43% below the market average21.43% below the market average21.43% below the market average21.43% below the market average21.43% below the market average
22.76% below the sector average22.76% below the sector average22.76% below the sector average22.76% below the sector average22.76% below the sector average
Income Not Available
Growth
66.11% above the market average66.11% above the market average66.11% above the market average66.11% above the market average66.11% above the market average
69.35% above the sector average69.35% above the sector average69.35% above the sector average69.35% above the sector average69.35% above the sector average

What The Brokers Say

Strong Buy 5
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 5
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Amryt Pharma Dividends

No dividends found

Trades for 27-Jul-2021

Time Volume / Share Price
10:24 2,447 @ 166.82p
09:45 77 @ 168.00p

Amryt Pharma Key Personnel

CEO Joe Wiley

Top of Page